Robert Doebele

Insider Reports History

Location
Newark, CA
Signature
/s/ Jessica Oien, Attorney-in- Fact for Robert Doebele.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Doebele:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rain Oncology Inc. President, Chief Scientific Officer Common Stock, par value $0.001 per share 0 $0 $1.21 26 Jan 2024 Direct
Boundless Bio, Inc. Chief Medical Officer Stock Option 180,000 03 Feb 2025 Direct
Rain Oncology Inc. President, Chief Scientific Officer Stock Option (Right to Buy) 0 26 Jan 2024 Direct

Insider Reports Filed by Robert Doebele

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BOLD Boundless Bio, Inc. 03 Feb 2025 1 $0 4 Chief Medical Officer 03 Feb 2025, 18:38
BOLD Boundless Bio, Inc. 03 Feb 2025 0 $0 3 Chief Medical Officer 03 Feb 2025, 18:29
RAIN Rain Oncology Inc. 26 Jan 2024 13 $0 4 President, Chief Scientific Officer 26 Jan 2024, 16:36
RAIN Rain Oncology Inc. 09 Aug 2023 2 $0 4 President, Chief Scientific Officer 11 Aug 2023, 21:16
RAIN Rain Oncology Inc. 15 Feb 2023 1 $0 4 President, Chief Scientific Officer 17 Feb 2023, 17:18
RAIN Rain Therapeutics Inc. 06 Jul 2022 2 $15,365 4 President, Chief Scientific Officer 07 Jul 2022, 18:02
RAIN Rain Therapeutics Inc. 13 Apr 2022 2 $11,850 4 President, Chief Scientific Officer 15 Apr 2022, 16:30
RAIN Rain Therapeutics Inc. 31 Mar 2022 2 $7,900 4 President, Chief Scientific Officer 04 Apr 2022, 16:15
RAIN Rain Therapeutics Inc. 07 Jan 2022 1 $0 4 EVP, Chief Scientific Officer 04 Feb 2022, 15:35